These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years. Bijlsma JW, Jacobs JW. Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732 [Abstract] [Full Text] [Related]
8. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW. Clin Exp Rheumatol; 2003 May; 21(2):155-60. PubMed ID: 12747268 [Abstract] [Full Text] [Related]
9. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M. Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [Abstract] [Full Text] [Related]
15. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis. Todoerti M, Scirè CA, Boffini N, Bugatti S, Montecucco C, Caporali R. Ann N Y Acad Sci; 2010 Apr; 1193():139-45. PubMed ID: 20398020 [Abstract] [Full Text] [Related]
16. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Book C, Karlsson M, Akesson K, Jacobsson L. Scand J Rheumatol; 2008 Apr; 37(4):248-54. PubMed ID: 18612924 [Abstract] [Full Text] [Related]
17. A fresh look at glucocorticoids how to use an old ally more effectively. Buttgereit F. Bull NYU Hosp Jt Dis; 2012 Apr; 70 Suppl 1():26-9. PubMed ID: 23259655 [Abstract] [Full Text] [Related]
18. Rheumatoid arthritis: Methotrexate and bridging glucocorticoids in early RA. Onuora S. Nat Rev Rheumatol; 2014 Dec; 10(12):698. PubMed ID: 25385411 [No Abstract] [Full Text] [Related]
19. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Hørslev-Petersen K, Hetland ML, Junker P, Pødenphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Johansen JS, Østergaard M, Stengaard-Pedersen K, OPERA Study-Group. Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570 [Abstract] [Full Text] [Related]
20. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE. Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]